B. Riley Wealth Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $258K | Buy |
+2,471
| New | +$258K | 0.01% | 757 |
|
2023
Q3 | – | Sell |
-3,347
| Closed | -$241K | – | 1474 |
|
2023
Q2 | $241K | Buy |
+3,347
| New | +$241K | 0.01% | 1248 |
|
2023
Q1 | – | Sell |
-3,361
| Closed | -$259K | – | 1527 |
|
2022
Q4 | $259K | Buy |
+3,361
| New | +$259K | 0.01% | 1111 |
|
2021
Q3 | – | Sell |
-4,147
| Closed | -$280K | – | 1415 |
|
2021
Q2 | $280K | Buy |
+4,147
| New | +$280K | 0.01% | 1056 |
|
2020
Q3 | – | Sell |
-6,450
| Closed | -$531K | – | 948 |
|
2020
Q2 | $531K | Buy |
+6,450
| New | +$531K | 0.04% | 441 |
|